0001011438-12-000203.txt : 20120508
0001011438-12-000203.hdr.sgml : 20120508
20120508145103
ACCESSION NUMBER: 0001011438-12-000203
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120331
FILED AS OF DATE: 20120508
DATE AS OF CHANGE: 20120508
EFFECTIVENESS DATE: 20120508
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Consonance Capital Management LP
CENTRAL INDEX KEY: 0001544773
IRS NUMBER: 260294313
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14924
FILM NUMBER: 12821016
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.660-8062
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
13F-HR
1
form_13f-consonance.txt
-----------------------------------
OMB APPROVAL
-----------------------------------
OMB Number: 3235-0006
Expires: August 31, 2012
Estimated average burden
hours per response..........22.6
-----------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: March 31, 2012
Check here if Amendment [ ]; Amendment Number:
This Amendment (Check only one.): [ ] is a restatement.
[ ] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Consonance Capital
Address: 888 Seventh Avenue, 43rd Floor
New York, New York 10019
Form 13F File Number:
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: Kevin H. Livingston
Title: Managing Director
Phone: 212-660-8060
Signature, Place, and Date of Signing:
/s/ Kevin H. Livingston New York, New York May 8, 2012
----------------------- -------------------- ---------------
[Signature] [City, State] [Date]
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT.(Check here if all holdings of this reporting manager
are reported in this report.)
[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)
[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).)
Form 13F Summary Page
Report Summary:
Number of Other Included Managers: 0
--------
Form 13F Information Table Entry Total: 13
--------
Form 13F Information Table Value Total: $124,435
--------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Form 13F File Number Name
--- -------------------- ----
Consonance Capital
Form 13F Information Table
Quarter ended March 31, 2012
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS or SH/ PUT/ INVE OTH VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISC MAN SOLE SHARED NONE
---------------------------- -------------- --------- --------- --------- --- ---- ---- --- --------- ------ ----
ABAXIS INC COM 002567105 $ 6,456 221,621 SH SOLE 221,621
BIOSCRIP INC COM 09069N108 $ 9,293 1,368,640 SH SOLE 1,368,640
CHINDEX INTERNATIONAL INC COM 169467107 $ 2,034 214,092 SH SOLE 214,092
COMPUTER PROGRAMS & SYS INC COM 205306103 $ 10,198 180,437 SH SOLE 180,437
EXPRESS SCRIPTS INC COM 302182100 $ 10,706 197,600 SH SOLE 197,600
MEDICINES CO COM 584688105 $ 9,256 461,200 SH SOLE 461,200
OPTIMER PHARMACEUTICALS INC COM 68401H104 $ 9,833 707,444 SH SOLE 707,444
QUESTCOR PHARMACEUTICALS INC COM 74835Y101 $ 14,294 379,952 SH SOLE 379,952
SANTARUS INC COM 802817304 $ 12,410 2,121,370 SH SOLE 2,121,370
SHANGPHARMA CORP SPONSORED ADR 81943P104 $ 4,587 566,318 SH SOLE 566,318
UNITED THERAPEUTICS CORP DEL COM 91307C102 $ 10,906 231,400 SH SOLE 231,400
WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 $ 7,619 529,100 SH SOLE 529,100
JAZZ PHARMACEUTICALS PLC SHS USD G50871105 $ 16,843 347,500 SH SOLE 347,500
Total Fair Market Value (in thousands): $124,435